中國衛生集團(00673.HK)以約逾2,500萬收購佑康健業60%股權
中國衛生集團(00673.HK)公布,透過全資附屬投資北京佑康健業醫療器械,當中包括180萬元人民幣(下同)注資及發行2.5億股股份的代價,收購目標公司的60%股權。另外,現有股東楊會軍及孫春雷各自將以現金形式分別向目標公司出資60萬元,各持股20%。
目標公司主要從事醫療器械及耗材分銷業務,其客戶基礎(包括北京-河北市場之知名醫院及醫療機構)以及分銷權(包括知名醫療器械品牌)預計將與現有醫藥分銷業務產生協同效應。
目標公司結欠投資者本金額100萬元,當中部分注資將通過於完成時抵銷該貸款之本金額支付。
公司通過按發行價每股代價股份0.1港元(較上一交易日收市溢價49.3%),向楊氏和孫氏持有之Best Robust配發及發行2.5億股代價股份之方式,向Best Robust支付2,500萬元代價。有關股份佔已發行股本的6.04%,或擴大後股本的5.69%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.